Noah A Levit

8PUBLICATIONS
27CO-AUTHORS
Behavioural epidemiologyInfant and child healthAllergyEpidemiological methodsToxicology (incl. clinical toxicology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jan 10, 2025
Development of novel patient-reported outcome instruments to assess atopic dermatitis-associated dyspigmentation and xerosis in patients with skin of colour.

Christopher Hartford, Andrew Alexis, Zhixiao Wang

|Sep 26, 2023
Dupilumab Safety and Efficacy in a Phase III Open-Label Extension Trial in Children 6-11 Years of Age with Severe Atopic Dermatitis.

Michael J Cork, Diamant Thaçi, Lawrence F Eichenfield

|May 16, 2023
Publisher Correction to: Efficacy and Safety of Dupilumab Maintained in Adults ≥ 60 Years of Age with Moderate-to-Severe Atopic Dermatitis: Analysis of Pooled Data from Four Randomized Clinical Trials.

Jonathan I Silverberg, Charles W Lynde, Katrina Abuabara

|Feb 22, 2023
Efficacy and Safety of Dupilumab Maintained in Adults ≥ 60 Years of Age with Moderate-to-Severe Atopic Dermatitis: Analysis of Pooled Data from Four Randomized Clinical Trials.

Jonathan I Silverberg, Charles W Lynde, Katrina Abuabara

|Dec 18, 2022
Laboratory Safety from a Randomized 16-Week Phase III Study of Dupilumab in Children Aged 6 Months to 5 Years with Moderate-to-Severe Atopic Dermatitis.

Amy S Paller, Elaine C Siegfried, Michael J Cork

|Jul 11, 2022
Dupilumab significantly improves skin barrier function in patients with moderate-to-severe atopic dermatitis.

Evgeny Berdyshev, Elena Goleva, Robert Bissonnette

Pageof 2

Frequent Collaborators

2 joint publications

Anna de Benedetto

2 joint publications

Cataldo Patruno

2 joint publications

Katrina Abuabara

2 joint publications

Jonathan I Silverberg